
FDA Draft Guidance on AI in Drug Development Explained
Examine the January 2025 FDA draft guidance on AI in drug development. This report details the 7-step credibility framework and excluded AI applications.

Examine the January 2025 FDA draft guidance on AI in drug development. This report details the 7-step credibility framework and excluded AI applications.

An in-depth case study of AstraZeneca's ChatGPT and generative AI implementation, updated for 2026. Covers enterprise strategy, R&D use cases, self-healing supply chains, and agentic AI adoption.
© 2026 IntuitionLabs. All rights reserved.